Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Similares em SciELO
Compartilhar
Cirugía y cirujanos
versão On-line ISSN 2444-054Xversão impressa ISSN 0009-7411
Resumo
MANTEROLA, Carlos; GRANDE, Luis; OTZEN, Tamara e CONEJEROS, Roque. Extension of surgical treatment and adjuvant chemotherapy in patients with incidental gallbladder cancer. Cir. cir. [online]. 2019, vol.87, n.3, pp.313-320. Epub 29-Nov-2021. ISSN 2444-054X. https://doi.org/10.24875/ciru.18000596.
Objective:
To describe the results of the extension of surgical treatment and adjuvant chemotherapy (ACT) in incidental gallbladder cancer (CVB), in terms of postoperative morbidity (POM) and 5-year overall survival rate.
Method:
Case series of patients operated on for incidental GBC in Clínica Mayor, Temuco, Chile (2001-2016). All cases were treated by partial hepatectomy (segments IVb and V), and regional lymphadenectomy. The minimum follow-up time was 12 months. Outcome variables were MPO and 5-year overall survival rate. Other variables of interest were: infiltration depth in vesicular wall, lymph nodes and resected liver; surgical time, need for reoperation, hospital stay, follow-up and mortality. Descriptive statistics were applied as well as bivariate analysis applying Fisher's exact and t-test and non-parametrical tests for continuous variables and Kaplan Meier curves.
Results:
The series was composed of 50 patients, whose average age was 58.6 ± 9.6 years; 68.0% of which were women. The mean surgical time and hospital stay were 224 ± 93 min (90 to 480) and 6.9 ± 2.9 days (4 to 20), respectively. POM was 28.0%. 5-year overall survival rate was 47%. There were no reoperations or mortality.
Conclusions:
The results verified in terms of POM and 5-year overall survival rate are similar to previously reported series.
Palavras-chave : Gallbladder cancer; Hepatectomy; Lymphadenectomy; Chemotherapy Adjuvant; Laparoscopic cholecystectomy; Kaplan-Meier.